4 terminated, 3 completed, 1 not yet recruiting, 1 recruiting. 10 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Terminated 4, Completed 3, Not yet recruiting 1, Recruiting 1, Suspended 1 |
| Phase 2 | 4 | Completed 1, Not yet recruiting 1, Recruiting 1, Terminated 1 |
Follow taxane: new trials by email Literature Review of taxane trials Research Report on taxane
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tocilizumab Combined With First-Line Chemo-Immunotherapy in Metastatic Non-Small Cell Lung Cancer Tocilizumab, Pembrolizumab, Platinum-Doublet Chemotherapy - Metastatic Non-Small Cell Lung Cancer, Cancer-Associated Weight Loss | Phase 1 / Phase 2 | Not yet recruiting | VA Office of Research and Development | 43 | 2026-11-01 | 2026-10-22 |
| ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors ABL103, KEYTRUDA® (pembrolizumab), Taxane - Solid Tumors | Phase 1 / Phase 2 | Recruiting | ABL Bio, Inc. | 65 | 2025-08-06 | 2025-09-08 |
| Pulsed Electromagnetic Fields (PEMFs) - A Highly Selective Breast CAncer Treatment pLatform (PASCAL) Pulsed electromagnetic fields (PEMFs), Device: Pulsed electromagnetic fields (PEMFs); Drug: Anthracycline OR Taxane - Breast Cancer | Phase 1 | Completed | National University Hospital, Singapore | 14 | 2022-12-30 | 2026-03-13 |
| A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer BMS-986442, Nivolumab, Docetaxel - Advanced Solid Tumors, Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Terminated | Bristol-Myers Squibb | 36 | 2022-10-04 | 2025-03-18 |
| First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers. GRN-300, Paclitaxel - Ovarian Tumors | Phase 1 | Suspended | Green3Bio, Inc. | 73 | 2020-12-21 | 2024-01-23 |
| Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases TPI 287, Fractionated Stereotactic Radiotherapy (FSRT) - Brain Metastases, Generalized Malignancy, Primary | Phase 1 | Terminated | H. Lee Moffitt Cancer Center and Research Institute | 15 | 2014-10-09 | 2021-02-04 |
| A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer BIIB022 With Paclitaxel and Carboplatin - Non-Small Cell Lung Cancer | Phase 1 | Completed | Biogen | 18 | 2009-10-01 | 2013-09-16 |
| A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer Oral Taxane - Cancer | Phase 1 | Terminated | Bristol-Myers Squibb | 36 | 2006-12-01 | 2010-03-02 |
| A Phase I Study of a Single Dose of Radio-labeled BMS-275183 in Patients With Advanced Cancer Oral Taxane - Cancer | Phase 1 | Terminated | Bristol-Myers Squibb | 6 | 2006-04-01 | 2010-03-02 |
| Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer Oral Taxane - Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Completed | Bristol-Myers Squibb | 2010-03-02 |
Carcinoma, Non-Small-Cell Lung (4) · Neoplasms (2) · Brain Neoplasms (1) · Breast Neoplasms (1) · Neoplasm Metastasis (1) · Ovarian Neoplasms (1)
Bristol-Myers Squibb (4) · ABL Bio, Inc. (1) · Biogen (1) · Green3Bio, Inc. (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · National University Hospital, Singapore (1) · VA Office of Research and Development (1)
United States (9) · Australia (2) · Canada (1) · Italy (1) · Netherlands (1) · Poland (1) · Singapore (1) · South Korea (1) · Spain (1)
Charles J Nock, MD (1) · Rachel Wong, Medical Degree (1) · Sangmi Lee (1) · Siqing Fu, MD, PhD (1) · Solmaz Sahebjam, M.D. (1)